MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,532,540 | +169.2% | 1,228,938 | +123.3% | 0.01% | +200.0% |
| Q2 2023 | $19,882,990 | +215.4% | 550,318 | +224.6% | 0.00% | +100.0% |
| Q1 2023 | $6,303,646 | -65.9% | 169,544 | -58.4% | 0.00% | -50.0% |
| Q4 2022 | $18,486,616 | +2.4% | 408,003 | +57.8% | 0.00% | +33.3% |
| Q3 2022 | $18,052,000 | +20.0% | 258,486 | +15.3% | 0.00% | 0.0% |
| Q2 2022 | $15,045,000 | +81.5% | 224,120 | +122.3% | 0.00% | +50.0% |
| Q1 2022 | $8,289,000 | -75.2% | 100,811 | -55.7% | 0.00% | -66.7% |
| Q4 2021 | $33,409,000 | -35.7% | 227,749 | -22.5% | 0.01% | -40.0% |
| Q3 2021 | $51,991,000 | -43.3% | 293,890 | -48.3% | 0.01% | -52.4% |
| Q2 2021 | $91,748,000 | -5.9% | 567,997 | -0.2% | 0.02% | -8.7% |
| Q1 2021 | $97,455,000 | +26.5% | 568,915 | +62.1% | 0.02% | +15.0% |
| Q4 2020 | $77,066,000 | +145.0% | 350,873 | +85.3% | 0.02% | +122.2% |
| Q3 2020 | $31,450,000 | +53.3% | 189,395 | +5.4% | 0.01% | +28.6% |
| Q2 2020 | $20,515,000 | -12.7% | 179,682 | -41.2% | 0.01% | -30.0% |
| Q1 2020 | $23,507,000 | -58.2% | 305,797 | -29.9% | 0.01% | -58.3% |
| Q4 2019 | $56,221,000 | -19.1% | 436,293 | -51.1% | 0.02% | -25.0% |
| Q3 2019 | $69,503,000 | -10.6% | 892,107 | +18.1% | 0.03% | -8.6% |
| Q2 2019 | $77,779,000 | +984.6% | 755,140 | +671.7% | 0.04% | +1066.7% |
| Q1 2019 | $7,171,000 | +287.6% | 97,849 | +124.3% | 0.00% | +200.0% |
| Q4 2018 | $1,850,000 | -68.3% | 43,624 | -64.7% | 0.00% | -50.0% |
| Q3 2018 | $5,827,000 | +226.6% | 123,701 | +241.8% | 0.00% | – |
| Q2 2018 | $1,784,000 | +18.1% | 36,189 | -26.4% | 0.00% | -100.0% |
| Q1 2018 | $1,510,000 | +175.5% | 49,176 | +63.7% | 0.00% | – |
| Q4 2017 | $548,000 | +104.5% | 30,048 | +31.5% | 0.00% | – |
| Q3 2017 | $268,000 | +145.9% | 22,855 | +38.6% | 0.00% | – |
| Q3 2016 | $109,000 | -9.2% | 16,493 | -25.2% | 0.00% | – |
| Q2 2016 | $120,000 | -56.2% | 22,064 | +72.3% | 0.00% | – |
| Q1 2016 | $274,000 | -72.0% | 12,806 | -58.6% | 0.00% | -100.0% |
| Q4 2015 | $977,000 | -76.8% | 30,916 | -74.7% | 0.00% | -75.0% |
| Q3 2015 | $4,203,000 | – | 122,126 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |